ORGENESIS APPROVED FOR 2.015.000 EUROS GRANT.

 
FREE EXCERPT

Orgenesis SPRL, a subsidiary of Orgenesis Inc., has received the formal approval from the Walloon Region, Belgium (Service Public of Wallonia, DG06) for a 2.015 million support program for the research and development of a potential cure for Type 1 Diabetes.

The Financial support is composed of a 1,085,000 euros (70% of budgeted costs) grant for the industrial research part of the research program and a further recoverable advance of 930,000 euros (60% of budgeted costs) of the experimental development part of the research program. The grants will be paid to Orgenesis over a period of approximately 3 years. The grants are subject to certain conditions respecting our conducting the work in the Walloon Region, our own investment in these projects and...

To continue reading

FREE SIGN UP